b'After losing Rishi to pediatric cancer,Im deeply committed to developingtreatments that will offer hope to families.SUJATHA VENKATARAMAN, Ph.D.FOUNDER, VINA ONCOLOGYSome promising products end up sitting on a shelf without everLife Sciences Leaders Accelerate advancing to a clinical trial, she explained. We founded VinaDiscovery with Unmatched Focus to bridge that gap and maintain control of the translation process, accelerate the innovation, and take this product to the clinic,Colorado innovators are translating ideas into impact by because it will bring hope to families like mine. advancing therapies, tools, and technologies designed to address some of healthcares most complex challenges.For Venkataraman, the work is profoundly personal. Sometimes families visit the lab to see how their childs tumor samples areTheir work reflects a rapidly evolving ecosystem that values being used. Its deeply emotional and I see myself in every onecollaboration, precision, and perseverance. In Colorado, inno-of them. It is a strong reminder that you should do somethingvation thrives when rigorous science meets lived experience. to save these kids quickly, she said.Whether propelled by data or driven by personal journeys, these changemakers share the belief that real progress Even if one child is cured, Ill feel I have fulfilled my purpose.happens when discovery and purpose converge. After losing Rishi to pediatric cancer, Im deeply committed to developing treatments that will offer hope to families.12 BIOSCIENCE COLORADO 2025-2026'